AcuCort AB (publ) (XSAT:ACUC)
0.9100
+0.0540 (6.31%)
At close: Feb 3, 2026
AcuCort AB Company Description
AcuCort AB (publ) operates as a pharmaceutical company.
It offers Zeqmelit, an oral film containing the glucocorticoid dexamethasone for the treatment of acute allergic reactions, croup in children, nausea and vomiting associated with chemotherapy, and for the treatment of patients with COVID-19 who experience respiratory difficulties and require oxygen therapy.
The company was incorporated in 2006 and is based in Lund, Sweden.
AcuCort AB (publ)
| Country | Sweden |
| Founded | 2006 |
| Industry | Pharmaceutical Preparations |
| Employees | 4 |
| CEO | Jonas Jonmark |
Contact Details
Address: Medicon Village Lund, 223 81 Sweden | |
| Website | acucort.com |
Stock Details
| Ticker Symbol | ACUC |
| Exchange | Spotlight Stock Market |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Jonas Jonmark | Chief Executive Officer |